JBIO
Price
$9.72
Change
+$0.47 (+5.08%)
Updated
Jun 27, 01:05 PM (EDT)
Capitalization
298.18M
45 days until earnings call
KPRX
Price
$3.02
Change
-$0.01 (-0.33%)
Updated
Jun 27, 01:04 PM (EDT)
Capitalization
9.22M
Interact to see
Advertisement

JBIO vs KPRX

Header iconJBIO vs KPRX Comparison
Open Charts JBIO vs KPRXBanner chart's image
Jade Biosciences
Price$9.72
Change+$0.47 (+5.08%)
Volume$200
Capitalization298.18M
Kiora Pharmaceuticals
Price$3.02
Change-$0.01 (-0.33%)
Volume$1K
Capitalization9.22M
JBIO vs KPRX Comparison Chart in %
Loading...
JBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
JBIO vs. KPRX commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JBIO is a StrongBuy and KPRX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 27, 2025
Stock price -- (JBIO: $9.25 vs. KPRX: $3.03)
Brand notoriety: JBIO and KPRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: JBIO: 48% vs. KPRX: 3%
Market capitalization -- JBIO: $298.18M vs. KPRX: $9.22M
JBIO [@Biotechnology] is valued at $298.18M. KPRX’s [@Biotechnology] market capitalization is $9.22M. The market cap for tickers in the [@Biotechnology] industry ranges from $113.86B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

JBIO’s FA Score shows that 1 FA rating(s) are green whileKPRX’s FA Score has 2 green FA rating(s).

  • JBIO’s FA Score: 1 green, 4 red.
  • KPRX’s FA Score: 2 green, 3 red.
According to our system of comparison, KPRX is a better buy in the long-term than JBIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

JBIO’s TA Score shows that 3 TA indicator(s) are bullish while KPRX’s TA Score has 2 bullish TA indicator(s).

  • JBIO’s TA Score: 3 bullish, 5 bearish.
  • KPRX’s TA Score: 2 bullish, 7 bearish.
According to our system of comparison, JBIO is a better buy in the short-term than KPRX.

Price Growth

JBIO (@Biotechnology) experienced а -1.70% price change this week, while KPRX (@Biotechnology) price change was +0.33% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.94%. For the same industry, the average monthly price growth was +39.30%, and the average quarterly price growth was +17.54%.

Reported Earning Dates

JBIO is expected to report earnings on Aug 11, 2025.

KPRX is expected to report earnings on May 09, 2025.

Industries' Descriptions

@Biotechnology (+9.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JBIO($298M) has a higher market cap than KPRX($9.22M). JBIO YTD gains are higher at: 249.057 vs. KPRX (-8.182).
JBIOKPRXJBIO / KPRX
Capitalization298M9.22M3,231%
EBITDAN/A-9.57M-
Gain YTD249.057-8.182-3,044%
P/E RatioN/A3.67-
RevenueN/A0-
Total CashN/A24.1M-
Total DebtN/A159K-
FUNDAMENTALS RATINGS
KPRX: Fundamental Ratings
KPRX
OUTLOOK RATING
1..100
94
VALUATION
overvalued / fair valued / undervalued
1..100
23
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
JBIOKPRX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
70%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 8 days ago
80%
Declines
ODDS (%)
Bearish Trend 15 days ago
90%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
JBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FBCVX24.08N/A
N/A
Fidelity Blue Chip Value
TEMLX8.80N/A
N/A
Nuveen Emerging Markets Eq R6
DHIAX19.43N/A
N/A
Diamond Hill International Inv
AEIMX8.56N/A
N/A
American Century Equity Income G
PAHWX8.40N/A
N/A
PGIM Jennison Intl Sm-Md Cap Opps A

JBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, JBIO has been closely correlated with OVID. These tickers have moved in lockstep 79% of the time. This A.I.-generated data suggests there is a high statistical probability that if JBIO jumps, then OVID could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JBIO
1D Price
Change %
JBIO100%
-11.99%
OVID - JBIO
79%
Closely correlated
+9.06%
KNSA - JBIO
35%
Loosely correlated
+0.39%
SYRE - JBIO
30%
Poorly correlated
+3.96%
KPRX - JBIO
29%
Poorly correlated
N/A
VANI - JBIO
26%
Poorly correlated
+3.15%
More

KPRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, KPRX has been loosely correlated with OVID. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if KPRX jumps, then OVID could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KPRX
1D Price
Change %
KPRX100%
N/A
OVID - KPRX
35%
Loosely correlated
+9.06%
PRME - KPRX
33%
Poorly correlated
+9.50%
AKTX - KPRX
30%
Poorly correlated
+0.86%
MTVA - KPRX
30%
Poorly correlated
+0.10%
TCRT - KPRX
29%
Poorly correlated
+11.31%
More